COMMUNIQUÉS West-GlobeNewswire

-
VALNEVA : Bilan semestriel du contrat de liquidité
04/07/2018 -
New software application provides Canadians easy access to healthcare through their smart device
04/07/2018 -
Theratechnologies Submits Novel Single-Vial Formulation of EGRIFTA® (Tesamorelin for Injection) for FDA Approval
04/07/2018 -
Theratechnologies soumet à la FDA une nouvelle formulation d’EGRIFTA(MD) (tésamoréline pour injection) en fiole unique
04/07/2018 -
VitalHub Announces Results of June 2018 AGM
04/07/2018 -
CORRECTION FIT Biotech Oy: FIT Biotech's company site has been launched in Inderes.fi
04/07/2018 -
Solon Eiendom ASA : Primary insider notification
04/07/2018 -
FIT Biotech Oy: FIT Biotech's company site has been launched in Inderes.fi
04/07/2018 -
Shire plc : Rule 2.9 Announcement
04/07/2018 -
Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/07/2018 -
BeiGene Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
03/07/2018 -
GBT Announces New Employment Inducement Grants
03/07/2018 -
Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
03/07/2018 -
Cue Health Receives ISO 13485 Certification
03/07/2018 -
AB Science : Résultats de l'Assemblée Générale Mixte du 29 juin 2018
03/07/2018 -
AB Science situation and future prospects presented during the Combined General Shareholders' Meeting held on July 29 2018
03/07/2018 -
AB Science : Situation et les perspectives de l'entreprise présentées lors de l'Assemblée Générale Mixte du 29 juillet 2018
03/07/2018 -
Capital Increase in Genmab as a Result of Employee Warrant Exercise
03/07/2018 -
EUROBIO SCIENTIFIC : BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITÉ CONCLU AVEC LA SOCIÉTÉ DE BOURSE GILBERT DUPONT
03/07/2018
Pages